Recent Updates
Recently added Catalysts
GEHC Positive Sentiment

GE HealthCare announces cash dividend increase for third quarter of 2026

Tuesday, September 22, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: GE HealthCare Technologies Inc. has announced a cash dividend of $0.04 per share for the third quarter of 2026, marking a 14% increase from the previous quarter. This dividend will be payable on November 13, 2026, to shareholders on record as of October 23, 2026. The announcement reflects the company's strong financial performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dividend increased by 14%, indicating financial growth.
  • Shareholders will receive payments on time.
  • Positive outlook for future dividends.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
2.5%
average across 3 past catalysts
Lead asset
PET MPI
Phase 3 · Coronary Artery Disease (CAD)

Full Press Release Details

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical dia

Frequently Asked Questions

What is the new dividend amount for GE HealthCare?

The new dividend amount is $0.04 per share.

When will the dividend be paid?

The dividend will be paid on November 13, 2026.

What was the percentage increase in the dividend?

The dividend increased by 14% from the previous quarter.

Who will receive the dividend?

All shareholders of record as of October 23, 2026, will receive the dividend.

ShareAdd on Google
Tags: GEHC Viatris Investor Conferences Healthcare GE HealthCare dividend financial growth cash dividend 2026
Last updated: Sep 22, 2026

Biotech snapshot

Cash runway
$2079M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PET MPIPhase 3
Coronary Artery Disease (CAD) →

Catalyst track record

+32%
best trade around GEHC's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for GEHC.

See every catalyst's timing & PoA →